Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study

Hossein Bahrami1, Matthew Budoff2, Sabina A Haberlen3

  • 1Division of Cardiovascular Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA Cardiovascular Institute and Division of Cardiovascular Medicine, Stanford University, Stanford, CA hbahrami@usc.edu.

Insights

HIV+ men show higher coronary artery disease risk due to elevated inflammatory markers like interleukin-6. These markers correlate with increased coronary stenosis and calcification, highlighting the need for further research into these pathways.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • HIV infection is linked to increased coronary artery disease (CAD) risk.
  • Mechanisms underlying CAD in HIV+ individuals remain unclear.
  • Subclinical atherosclerosis assessment is crucial for understanding CAD risk.

Purpose of the Study:

  • To investigate the association between inflammatory markers and subclinical coronary artery disease (CAD) in HIV+ men.
  • To compare CAD markers between HIV+ and HIV- men.
  • To identify specific inflammatory pathways contributing to CAD in HIV+ individuals.

Main Methods:

  • Utilized data from 923 Multicenter AIDS Cohort Study participants (575 HIV+, 348 HIV-).
  • Assessed coronary artery calcification (CAC) using noncontrast computed tomography (CT).
  • Analyzed coronary plaque characteristics and stenosis severity via coronary CT angiography (CCTA).

Main Results:

  • HIV+ men exhibited higher levels of interleukin-6 (IL-6), intercellular adhesion molecule-1, C-reactive protein, and soluble-tumor necrosis factor-α receptors (sTNFαR) I and II.
  • A greater prevalence of noncalcified plaque was observed in HIV+ men (63% vs. 54%).
  • Elevated IL-6, intercellular adhesion molecule-1, sTNFαR I, and sTNFαR II were significantly associated with increased coronary stenosis and CAC score in HIV+ men.

Conclusions:

  • Higher inflammatory marker levels correlate with increased coronary stenosis prevalence in HIV+ men.
  • Inflammatory pathways play a significant role in CAD development among HIV+ individuals.
  • Further research is needed to elucidate the precise relationships between inflammation and CAD in the context of HIV infection.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
715
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
522
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
647
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384